Ghent University Academic Bibliography

Your filters: cql: author="Nguyen, Ai-Lan" or (type any "bookEditor issueEditor" and editor="Nguyen, Ai-Lan")

Add to list
- Journal Article
- A2
- open access
Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry

Ai-Lan Nguyen, Dana Horakova, Eva H Havrdova, Michael Barnett, Maria Pia Sormani, Nicola De Stefano, Marco Battaglini, Manuela Vaneckova, Elaine Lui, Frank Gaillard, et al.

(2025) BMJ NEUROLOGY OPEN. 7(2).
Add to list
- Journal Article
- A1
- open access
Utility of icobrain for brain volumetry in multiple sclerosis clinical practice

Ai-Lan Nguyen, Maria Pia Sormani, Dana Horakova, Eva H Havrdova, Michael H Barnett, Nicola De Stefano, Marco Battaglini, Manuela Vaneckova, Elaine Lui, Frank Gaillard, et al.

(2024) MULTIPLE SCLEROSIS AND RELATED DISORDERS. 92.
Add to list
- Journal Article
- A1
- open access
Disability accrual in primary and secondary progressive multiple sclerosis

Sam Harding-Forrester, Izanne Roos, Ai-Lan Nguyen, Charles B Malpas, Ibrahima Diouf, Nahid Moradi, Sifat Sharmin, Guillermo Izquierdo, Sara Eichau, Francesco Patti, et al.

(2023) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 94(9). p.707-717
Add to list
- Journal Article
- A1
- open access
Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

Izanne Roos, Stella Hughes, Gavin McDonnell, Charles B. Malpas, Sifat Sharmin, Cavit Boz, Raed Alroughani, Serkan Ozakbas, Katherine Buzzard, Olga Skibina, et al.

(2023) JAMA NEUROLOGY. 80(8). p.789-797
Add to list
- Journal Article
- A1
- open access
Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

Tomas Kalincik, Sifat Sharmin, Izanne Roos, Mark S. Freedman, Harold Atkins, Joachim Burman, Jennifer Massey, Ian Sutton, Barbara Withers, Richard Macdonell, et al.

(2023) JAMA NEUROLOGY. 80(7). p.702-713

Academic Bibliography

Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry

Utility of icobrain for brain volumetry in multiple sclerosis clinical practice

Disability accrual in primary and secondary progressive multiple sclerosis

Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

Contents

Support

Contact